Net sales increased 5.2% YoY and 3.4% against the plan due to increase of sales in dispensing pharmacy business, despite the impact of the COVID-19. Ordinary profit increased 35.6% YoY and 9.4% against the plan due to increase of sales.
Net sales increased 6.9% YoY and 5.0% against the plan due to the recovery in prescription volume at existing stores and the contribution of stores opened in previous year. Segment profit increased 25.3% YoY and 12.8% against the plan due to increase of sales.
Net sales up 4.6% YoY and declined 7.7% against the plan due to the recovery of existing stores and contribution of stores opened in previous year despite the impact of temporarily shorted opening hours and refrainment from going out under the spread of COVID-19. Segment loss was ¥1,125 million, ¥195 million below the plan.
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
Original Link
Original Document
Permalink
Disclaimer
AIN Holdings Inc. published this content on 10 December 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 10 December 2021 01:51:03 UTC.
Ain Holdings Inc, is a Japan-based company engaged in the operation of pharmacies and retail business. The Company has three business segments. The Pharmacy segment operates and franchises pharmacies, and provides consulting services related to opening pharmacies. Through its subsidiaries, this segment is also involved in the provision of consultation services for medical-related affairs and manpower dispatching of doctors and pharmacists, as well as the sale of generic drugs. The Retail segment operates cosmetics business and drugstores. The Others segment is engaged in the leasing of buildings and the sales of cosmetics.
AIN HOLDINGS INC. 
